Table of Content

1 Live Vaccines Market Overview
1.1 Product Overview and Scope of Live Vaccines
1.2 Live Vaccines Segment by Type
1.2.1 Global Live Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Monovalent Live Vaccines
1.2.3 Multivalent Live Vaccines
1.3 Live Vaccines Segment by Application
1.3.1 Live Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Adults
1.3.3 Children
1.4 Global Live Vaccines Market Size Estimates and Forecasts
1.4.1 Global Live Vaccines Revenue 2016-2027
1.4.2 Global Live Vaccines Sales 2016-2027
1.4.3 Live Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027

2 Live Vaccines Market Competition by Manufacturers
2.1 Global Live Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Live Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Live Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Live Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Live Vaccines Market Competitive Situation and Trends
2.5.1 Live Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Live Vaccines Players Market Share by Revenue
2.5.3 Global Live Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Live Vaccines Retrospective Market Scenario by Region
3.1 Global Live Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Live Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Live Vaccines Market Facts & Figures by Country
3.3.1 North America Live Vaccines Sales by Country
3.3.2 North America Live Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Live Vaccines Market Facts & Figures by Country
3.4.1 Europe Live Vaccines Sales by Country
3.4.2 Europe Live Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Live Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Live Vaccines Sales by Region
3.5.2 Asia Pacific Live Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Live Vaccines Market Facts & Figures by Country
3.6.1 Latin America Live Vaccines Sales by Country
3.6.2 Latin America Live Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Live Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Live Vaccines Sales by Country
3.7.2 Middle East and Africa Live Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Live Vaccines Historic Market Analysis by Type
4.1 Global Live Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Live Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Live Vaccines Price by Type (2016-2021)

5 Global Live Vaccines Historic Market Analysis by Application
5.1 Global Live Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Live Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Live Vaccines Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Live Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Live Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GlaxoSmithKline Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Live Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Live Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Astellas Pharma
6.5.1 Astellas Pharma Corporation Information
6.5.2 Astellas Pharma Description and Business Overview
6.5.3 Astellas Pharma Live Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Astellas Pharma Product Portfolio
6.5.5 Astellas Pharma Recent Developments/Updates
6.6 Emergent BioSolutions
6.6.1 Emergent BioSolutions Corporation Information
6.6.2 Emergent BioSolutions Description and Business Overview
6.6.3 Emergent BioSolutions Live Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Emergent BioSolutions Product Portfolio
6.6.5 Emergent BioSolutions Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Live Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 AstraZeneca Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates

7 Live Vaccines Manufacturing Cost Analysis
7.1 Live Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Live Vaccines
7.4 Live Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Live Vaccines Distributors List
8.3 Live Vaccines Customers

9 Live Vaccines Market Dynamics
9.1 Live Vaccines Industry Trends
9.2 Live Vaccines Growth Drivers
9.3 Live Vaccines Market Challenges
9.4 Live Vaccines Market Restraints

10 Global Market Forecast
10.1 Live Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Live Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Live Vaccines by Type (2022-2027)
10.2 Live Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Live Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Live Vaccines by Application (2022-2027)
10.3 Live Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Live Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Live Vaccines by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Live Vaccines Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Live Vaccines Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global Live Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Live Vaccines Covered in This Study
Table 5. Global Live Vaccines Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Live Vaccines Sales Share by Manufacturers (2016-2021)
Table 7. Global Live Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Live Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Live Vaccines Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Live Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Live Vaccines Product Type
Table 12. Global Live Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Live Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Live Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Live Vaccines Sales by Region (2016-2021) & (K Doses)
Table 16. Global Live Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Live Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Live Vaccines Sales by Country (2016-2021) & (K Doses)
Table 19. North America Live Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Live Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Live Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Live Vaccines Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Live Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Live Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Live Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Live Vaccines Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Live Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Live Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Live Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Live Vaccines Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Live Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Live Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Live Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Live Vaccines Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Live Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Live Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Live Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Live Vaccines Sales (K Doses) by Type (2016-2021)
Table 39. Global Live Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Live Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Live Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Live Vaccines Price (USD/Dose) by Type (2016-2021)
Table 43. Global Live Vaccines Sales (K Doses) by Application (2016-2021)
Table 44. Global Live Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Live Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Live Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Live Vaccines Price (USD/Dose) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Live Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. Merck Live Vaccines Product
Table 52. Merck Recent Developments/Updates
Table 53. GlaxoSmithKline Corporation Information
Table 54. GlaxoSmithKline Description and Business Overview
Table 55. GlaxoSmithKline Live Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. GlaxoSmithKline Live Vaccines Product
Table 57. GlaxoSmithKline Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Live Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Pfizer Live Vaccines Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Novartis Corporation Information
Table 64. Novartis Description and Business Overview
Table 65. Novartis Live Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. Novartis Live Vaccines Product
Table 67. Novartis Recent Developments/Updates
Table 68. Astellas Pharma Corporation Information
Table 69. Astellas Pharma Description and Business Overview
Table 70. Astellas Pharma Live Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Astellas Pharma Live Vaccines Product
Table 72. Astellas Pharma Recent Developments/Updates
Table 73. Emergent BioSolutions Corporation Information
Table 74. Emergent BioSolutions Description and Business Overview
Table 75. Emergent BioSolutions Live Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Emergent BioSolutions Live Vaccines Product
Table 77. Emergent BioSolutions Recent Developments/Updates
Table 78. AstraZeneca Corporation Information
Table 79. AstraZeneca Description and Business Overview
Table 80. AstraZeneca Live Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. AstraZeneca Live Vaccines Product
Table 82. AstraZeneca Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Live Vaccines Distributors List
Table 86. Live Vaccines Customers List
Table 87. Live Vaccines Market Trends
Table 88. Live Vaccines Growth Drivers
Table 89. Live Vaccines Market Restraints
Table 90. Global Live Vaccines Sales Forecast by Type (2022-2027) & (K Doses)
Table 91. Global Live Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Live Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Live Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Live Vaccines Sales Forecast by Application (2022-2027) & (K Doses)
Table 95. Global Live Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Live Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Live Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Live Vaccines Sales Forecast by Region (2022-2027) & (K Doses)
Table 99. Global Live Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Live Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Live Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Live Vaccines
Figure 2. Global Live Vaccines Market Share by Type in 2020 & 2027
Figure 3. Monovalent Live Vaccines Product Picture
Figure 4. Multivalent Live Vaccines Product Picture
Figure 5. Global Live Vaccines Market Share by Application in 2020 & 2027
Figure 6. Adults
Figure 7. Children
Figure 8. Global Live Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Live Vaccines Market Size 2016-2027 (US$ Million)
Figure 10. Global Live Vaccines Sales 2016-2027 (K Doses)
Figure 11. Global Live Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Live Vaccines Sales Share by Manufacturers in 2020
Figure 13. Global Live Vaccines Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Live Vaccines Players: Market Share by Revenue in 2020
Figure 15. Live Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Live Vaccines Sales Market Share by Region (2016-2021)
Figure 17. Global Live Vaccines Sales Market Share by Region in 2020
Figure 18. Global Live Vaccines Revenue Market Share by Region (2016-2021)
Figure 19. Global Live Vaccines Revenue Market Share by Region in 2020
Figure 20. U.S. Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Live Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Live Vaccines by Type (2016-2021)
Figure 45. Sales Market Share of Live Vaccines by Application (2016-2021)
Figure 46. Sales Market Share of Live Vaccines by Application in 2020
Figure 47. Revenue Share of Live Vaccines by Application (2016-2021)
Figure 48. Revenue Share of Live Vaccines by Application in 2020
Figure 49. Manufacturing Cost Structure of Live Vaccines
Figure 50. Manufacturing Process Analysis of Live Vaccines
Figure 51. Live Vaccines Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed